Annual Accounts Payable
$507.00 K
-$5.86 M-92.03%
December 31, 2023
Summary
- As of February 8, 2025, ELEV annual accounts payable is $507.00 thousand, with the most recent change of -$5.86 million (-92.03%) on December 31, 2023.
- During the last 3 years, ELEV annual accounts payable has fallen by -$5.17 million (-91.07%).
- ELEV annual accounts payable is now -92.03% below its all-time high of $6.36 million, reached on December 31, 2022.
Performance
ELEV Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.63 M
+$2.29 M+664.83%
September 30, 2024
Summary
- As of February 8, 2025, ELEV quarterly accounts payable is $2.63 million, with the most recent change of +$2.29 million (+664.83%) on September 30, 2024.
- Over the past year, ELEV quarterly accounts payable has stayed the same.
- ELEV quarterly accounts payable is now -58.65% below its all-time high of $6.36 million, reached on December 31, 2022.
Performance
ELEV Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ELEV Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -92.0% | 0.0% |
| 3 y3 years | -91.1% | -58.6% |
| 5 y5 years | +10.2% | -58.6% |
ELEV Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -92.0% | at low | -58.6% | +664.8% |
| 5 y | 5-year | -92.0% | +10.2% | -58.6% | +664.8% |
| alltime | all time | -92.0% | +10.2% | -58.6% | +664.8% |
Elevation Oncology Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.63 M(+664.8%) |
| Jun 2024 | - | $344.00 K(-20.9%) |
| Mar 2024 | - | $435.00 K(-14.2%) |
| Dec 2023 | $507.00 K(-92.0%) | $507.00 K(-86.1%) |
| Sep 2023 | - | $3.64 M(-30.5%) |
| Jun 2023 | - | $5.24 M(+29.6%) |
| Mar 2023 | - | $4.04 M(-36.5%) |
| Dec 2022 | $6.36 M | $6.36 M(+12.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $5.67 M(+337.1%) |
| Jun 2022 | - | $1.30 M(+46.9%) |
| Mar 2022 | - | $882.00 K(-84.4%) |
| Dec 2021 | $5.65 M(-0.5%) | $5.65 M(+3.9%) |
| Sep 2021 | - | $5.43 M(+478.8%) |
| Jun 2021 | - | $939.00 K(+39.7%) |
| Mar 2021 | - | $672.00 K(-88.2%) |
| Dec 2020 | $5.68 M(+1134.6%) | $5.68 M |
| Dec 2019 | $460.00 K | - |
FAQ
- What is Elevation Oncology annual accounts payable?
- What is the all time high annual accounts payable for Elevation Oncology?
- What is Elevation Oncology annual accounts payable year-on-year change?
- What is Elevation Oncology quarterly accounts payable?
- What is the all time high quarterly accounts payable for Elevation Oncology?
- What is Elevation Oncology quarterly accounts payable year-on-year change?
What is Elevation Oncology annual accounts payable?
The current annual accounts payable of ELEV is $507.00 K
What is the all time high annual accounts payable for Elevation Oncology?
Elevation Oncology all-time high annual accounts payable is $6.36 M
What is Elevation Oncology annual accounts payable year-on-year change?
Over the past year, ELEV annual accounts payable has changed by -$5.86 M (-92.03%)
What is Elevation Oncology quarterly accounts payable?
The current quarterly accounts payable of ELEV is $2.63 M
What is the all time high quarterly accounts payable for Elevation Oncology?
Elevation Oncology all-time high quarterly accounts payable is $6.36 M
What is Elevation Oncology quarterly accounts payable year-on-year change?
Over the past year, ELEV quarterly accounts payable has changed by $0.00 (0.00%)